{"transactions":[{"id":2897942,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T18:47:58.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service."}],"balance_after":115000,"derivative":{"exercise_price":3.05,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-005218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919121005218/doc4.xml","form_type":"4"}},{"id":2897941,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-25T18:47:58.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":700,"price":3.16,"value":2212.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-005218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919121005218/doc4.xml","form_type":"4"}},{"id":3183847,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-03T17:31:36.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal installments beginning April 30, 2020 and ending March 31, 2024."}],"balance_after":60000,"derivative":{"exercise_price":2.74,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-023345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919120023345/doc4.xml","form_type":"4"}}]}